Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Marlene Murphy

Pediatrics Sarasota, FL Medical Doctor

NPI 1326051558 CMS profile 241064

2020 Cattlemen Rd, Suite 600, Sarasota, FL 34232

Open in the dashboard

General payments

$4,238

227 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Marlene Murphy of Sarasota, FL is reported in the CMS Open Payments database as having received $4,238 across 227 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $696 27
2024 General $759 42
2023 General $437 24
2022 General $757 52
2021 General $691 45
2020 General $219 13
2019 General $678 24

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Marlene Murphy
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Marlene Murphy were reported at $696. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Marlene Murphy Pediatrics median Middle half National median
2019 $678 $86 $31–$183 $163
2020 $219 $49 $22–$110 $114
2021 $691 $68 $27–$158 $132
2022 $757 $77 $30–$173 $149
2023 $437 $88 $33–$190 $160
2024 $759 $94 $34–$206 $164
2025 $696 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Tris Pharma Inc $992 68 payments
  2. Ironshore Pharmaceuticals Inc. $522 17 payments
  3. Corium, Inc. $518 29 payments
  4. GlaxoSmithKline, LLC. $473 16 payments
  5. Pfizer Inc. $342 16 payments
  6. Merck Sharp & Dohme Corporation $271 19 payments
  7. Neos Therapeutics, LP $252 14 payments
  8. Takeda Pharmaceuticals U.S.A., Inc. $136 9 payments
  9. Sobi, Inc $123 7 payments
  10. kaleo, Inc. $122 8 payments
  11. Other $488 24 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,238 227 payments
Products named General payments · program years 2019–2025
  1. Dyanavel XR Adhd $539 34 payments
  2. Azstarys $518 29 payments
  3. BEXSERO $351 15 payments
  4. TRUMENBA $304 14 payments
  5. Jornay PM 20mg capsules (Bottle of 100) $297 6 payments
  6. PREVNAR 20 $221 9 payments
  7. Dyanavel XR Adhd $220 13 payments
  8. COTEMPLA XR-ODT $220 12 payments
  9. GARDASIL 9 $211 15 payments
  10. VAXNEUVANCE $182 12 payments
  11. Other $2,759 157 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

227 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record